176 related articles for article (PubMed ID: 24935473)
1. Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer.
Wang TY; Huang YP; Ma P
Tumour Biol; 2014 Sep; 35(9):9255-62. PubMed ID: 24935473
[TBL] [Abstract][Full Text] [Related]
2. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population.
Mu YP; Su XL
Med Oncol; 2012 Sep; 29(3):1723-32. PubMed ID: 22108846
[TBL] [Abstract][Full Text] [Related]
4. The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer.
Wang J; Shi Y; Wang G; Dong S; Yang D; Zuo X
Mol Genet Genomic Med; 2019 Aug; 7(8):e804. PubMed ID: 31297985
[TBL] [Abstract][Full Text] [Related]
5. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
6. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA
Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
8. Association of a potential functional mir-520f rs75598818 G>A polymorphism with breast cancer.
Meshkat M; Mesrian Tanha H; Ghaedi K; Meshkat M
J Genet; 2018 Dec; 97(5):1307-1313. PubMed ID: 30555079
[TBL] [Abstract][Full Text] [Related]
9. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
10. The impact of mitochondria-related
Golubickaite I; Ugenskiene R; Korobeinikova E; Gudaitiene J; Vaitiekus D; Poskiene L; Juozaityte E
Biomarkers; 2021 Jun; 26(4):343-353. PubMed ID: 33715547
[TBL] [Abstract][Full Text] [Related]
11. Association between Genetic Polymorphisms of miR-1307, miR- 1269, miR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women.
Sarabandi S; Sattarifard H; Kiumarsi M; Karami S; Taheri M; Hashemi M; Bahari G; Ghavami S
Asian Pac J Cancer Prev; 2021 Jan; 22(1):201-208. PubMed ID: 33507700
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
15. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
[TBL] [Abstract][Full Text] [Related]
16. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
[TBL] [Abstract][Full Text] [Related]
17. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.
Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849
[TBL] [Abstract][Full Text] [Related]
18. The role of base excision repair in pathogenesis of breast cancer in the Polish population.
Cuchra M; Mucha B; Markiewicz L; Przybylowska-Sygut K; Pytel D; Jeziorski A; Kordek R; Majsterek I
Mol Carcinog; 2016 Dec; 55(12):1899-1914. PubMed ID: 27870262
[TBL] [Abstract][Full Text] [Related]
19. The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk.
Cao S; Wei F; Zhou J; Zhu Z; Li W; Wu M
Breast Cancer Res Treat; 2020 Jan; 179(2):499-509. PubMed ID: 31696340
[TBL] [Abstract][Full Text] [Related]
20. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
